Wegovy study bolsters use in patients with obesity and heart disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss drug, to cut heart attacks and strokes in obesity patients with a history of cardiovascular disease.
Nov 13, 2023
0
0